Alterations in gallbladder emptying and bile retention in the absence of changes in bile lithogenicity in postmenopausal women on hormone replacement therapy

Digestive Diseases and Sciences

Volumn 49, Issue 7-8, 2004, Pages 1335-1341

  Dhiman, Radha K ^a   Sarkar, Pralay K ^a   Sharma, Arpita ^a   Vasishta, Kala ^a   Kohli, Krishan K ^a   Gupta, Sanjay ^a   Suri, Sudha ^a   Chawla, Yogesh ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

bile; estrogen; gallbladder motility; gallstones; hormone replacement therapy; menopause; progestin

Indexed keywords

ACETYLSALICYLIC ACID; CISAPRIDE; DOMPERIDONE; ERYTHROMYCIN; ESTROGEN; GESTAGEN; HORMONE; MEDROXYPROGESTERONE ACETATE; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROKINETIC AGENT;

ADULT; ARTICLE; BILE; CHOLELITHIASIS; CLINICAL ARTICLE; CRYSTAL; FEMALE; GALLBLADDER DISEASE; GALLBLADDER EMPTYING; GALLBLADDER MOTILITY; GALLSTONE; HEART EJECTION FRACTION; HEPATOBILIARY SYSTEM EXAMINATION; HORMONE SUBSTITUTION; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RESIDUAL VOLUME; SAMPLE;

BILE; CHOLECYSTOLITHIASIS; CHOLESTEROL; ESTROGEN REPLACEMENT THERAPY; FEMALE; GALLBLADDER EMPTYING; HUMANS; MIDDLE AGED; POSTMENOPAUSE;

EID: 4444234114     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000037831.77490.06     Document Type: Article

References (55)

1. Diehl AK: Epidemiology and natural history of gallstone disease. Gastrointest Clin North Am 20:1-19, 1991
2. Maringhini A, Ciambra M, Baccelliere P, et al.: Biliary sludge and gallstones in pregnancy: Incidence, risk factors and natural history. Ann Intern Med 119:116-120, 1993
3. Leissner KH, Wedel H, Schersten T: Comparison between the use of oral contraceptives and the incidence of surgically confirmed gallbladder disease. Scand J Gastroenterol 12:893-896, 1977
4. Scragg RK, McMichael AJ, Seamark RF: Oral contraceptives, pregnancy and endogenous estrogen in gallstone disease - A case-control study. Br Med J 288:1795-1799, 1984
5. Boston Collaborative Drug Surveillance Programme: Oral contraceptive, venous thromboembolic disease, surgically confirmed gallbladder disease and breat tumours. Lancet 1:1399-1404, 1973
6. Royal College of General Practitioners: Oral contraceptives and health. Manchester, UK, Pitman Medical, 1974, pp. 57-59
7. Uhler ML, Marks JW, Judd HL: Estrogen replacement therapy and gallbladder disease in postmenopausal women. Menopause 7:162-167, 2000
8. Vecchia CL, Negri E, D'Avanzo B, et al.: Oral contraceptive and noncontraceptive estrogens in the risk of gallstone disease requiring surgery. J Epidemiol Comm Health 46:234-236, 1992
9. Henriksson P, Einarsson K, Eriksson A, et al.: Estrogen induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma. J Clin Invest 84:811-816, 1989
10. Donovan JM: Physical and metabolic factors in gallstone pathogenesis. Gastrointest Clin N Am 28:75-98, 1999
11. Everson GT, McKinley C, Kern F Jr: Mechanism of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 87:237-246, 1991
12. Messa C, Maselli MA, Cavallini A, et al.: Sex steriod hormone receptors and human gallbladder motility in vitro. Digestion 46:214-219, 1990
13. Shaffer EA, Taylor PJ, Logan K, et al.: The effect of progestin on gallbladder function in young women. Am J Obstet Gynecol 148:504-507, 1984
14. Dodd W, Groh W, Darweesh R, et al.: Sonographic measurement of gallbladder volume. Am J Radiol 145:1009-1011, 1985
15. Dhiman RK, Reddi R, Sharma A, et al.: Cisapride improves gallbladder emptying and bile lipid composition in patients with gallstones. J Gastroenterol Hepatol 16:816-820, 2001
16. Dhiman RK, Arke L, Bhansali A, et al.: Cisapride improves gallbladder emptying in patients with diabetes mellitus. J Gastroenterol Hepatol 16:1044-1050, 2001
17. Dhiman RK, Phanish MK, Chawla YK, et al.: Gallbladder motility and lithogenicity of bile in patients with choledocholithiasis after endoscopic sphincterotomy. J Hepatol 26:1300-1305, 1997
18. Das A, Baijal SS, Saraswat VA: Effect of aspirin on gallbladder motility in patients with gallstone disease. A randomized, double blind, placebo control trial of two dosage schedules. Dig Dis Sci 40:1782-1785, 1995
19. Everson GT, Braverman DZ, Johnson ML, et al.: A critical evaluation of real time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology 79:40-46, 1980
20. Juniper K Jr, Burson EN Jr: Significance of biliary crystals. Gastroenterology 32:175-96, 1957
21. Holan R, Holzbach RT, Hermann RE, et al.: Nucleation time - A key factor in pathogenesis of gallstones. Gastroenterology 77:611-617, 1979
22. Marks JW, Broomfield P, Bonorris GG, et al.: Factors affecting the measurement of cholesterol nucleation in human gallbladder and duodenal bile. Gastroenterology 101:214-219, 1991
23. Sharma BC, Agarwal DK, Dhiman RK, et al.: Bile lithogenicity and gallbladder emptying in patients with microlithiasis: Effect of bile acid therapy. Gastroenterology 115:124-128, 1998
24. Leffler HH: Estimation of cholesterol in serum. Am J Clin Pathol 31:310-313, 1959
25. Fiske CH, Subbarow Y: The colorimetric determination of phosphorus. J Biol Chem 66:375-378, 1925
26. Turley SD, Dietschy JM: Re-evaluation of the 3α-hydroxysteroid dehydrogenase assay for total bile acids in bile. J Lipid Res 19:924-928, 1978
27. Carey MC: Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 19:945-955, 1978
28. BCDSP: Surgically confirmed gallbladder disease, venous thromboembolism and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program. Boston University Medical Center. N Engl J Med 290:15-19, 1974
29. Honore LH: Increased incidence of symptomatic cholesterol cholelithiasis in perimenopausal women receiving estrogen replacement therapy: A retrospective study. J Reprod Med. 25:187-190, 1980
30. Petitti DB, Friedman GD, Klatsky AL: Association of a history of gallbladder disease with a reduced concentration of high-density-lipoprotein cholesterol. N Engl J Med 304:1396-1398, 1981
31. Petitti DB, Sidney S, Perlman JA: Increased risk of cholecystectomy in users of supplemental estrogen. Gastroenterology. 94:91-95, 1988
32. La Vecchia C, Negri E, D'Avanzo B, et al.: Oral contraceptives and non-contraceptive oestrogens in the risk of gallstone disease requiring surgery. J Epidemiol Commun Health 46:234-236, 1992
33. Grodstein F, Colditz GA, Stampfer MJ: Postmenopausal hormone use and cholecystectomy in a large prospective study. Obstet Gynecol 83:5-11, 1994
34. Simon IA, Hunninghake DB, Agarwal SK, Lin F, Cauley JA, Ireland CC, Picker JH, for Heart and Estrogen/Progestion Replacement Study (HERS) research group. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. Ann Intern Med 135:493-501, 2001
35. CDP: Gallbladder disease as a side effect of drugs influencing lipid metabolism. Experience in the Coronary Drug Project. N Engl J Med 296:1185-1190, 1977
36. Kakar F, Weiss NS, Strite SA: Non-contraceptive use and risk of gallstone disease in women. Am J Public Health 78:564-566, 1988
37. Jorgensen T: Gall stones in a Danish population: Fertility period, pregnancies, and exogenous female sex hormones. Gut 29:433-439, 1988
38. Pomeranz IS, Shaffer EA: Abnormal gallbladder emptying in a subgroup of patients with gallstones. Gastroenterology 88:787-791, 1985
39. Fridhandler TM, Davison JS, Shaffer EA: Defective gallbladder contractility in the ground squirrel and prairie dog during the early stages of cholesterol gallstone formation. Gastroenterology 85:830-836, 1983
40. Jazrawi RP, Pazzi P, Petroni ML, et al.: Postprandial gallbladder motor function: Refilling and turnover of bile in health and in cholelithiasis. Gastroenterology 109:582-591, 1995
41. Braverman DZ, Johnson ML, Kern F Jr: Effects of pregnancy and contraceptive steroids on gallbladder function. N Engl J Med 302:362-364, 1980
42. Hould FS, Fried GM, Fazekas AG, et al.: Progesterone receptors regulate gallbladder motility. J Surg Res 45:505-512, 1988
43. Davis M, Ryan JP: Influence of progesterone on guinea pig gallbladder motility in vitro. Dig Dis Sci 31:513-518, 1986
44. Ryan JP: Effects of pregnancy on gallbladder contractility in the guinea pig. Gastroenterology 87:674-678, 1984
45. Ryan JP, Pellecchia D: Effect of progesterone treatment on guinea pig gallbladder motility in vitro. Gastroenterology 83:81-83, 1982
46. Gilloteaux J, Karkare S, Don AQ, et al.: Cholelithiasis induced in the Syrian hamster: Evidence for an intramucinous nucleating process and down regulation of cholesterol 7 alpha-hydroxylase (CYP7) gene by medroxyprogesterone. Microsc Res Tech 39:56-70, 1997
47. Chen Q, Amaral J, Biancani P, et al.: Excess membrane cholesterol alters human gallbladder muscle contractility and membrance fluidity. Gastroenterology 116:678-685, 1999
48. Whiting MJ, Down RHL, Watts JMcK: Precision and accuracy in the measurement of cholesterol saturation of bile. Gastroenterology 80:533-538, 1981
49. Kern F Jr, Everson GT, DeMark B, et al.: Biliary lipids, bile acids, and gallbladder function in the human female: Effects of pregnancy and ovulatory cycle. J Clin Invest 68:1229-1242, 1981
50. Valdivieso V, Covarrubias C, Siegel F, et al.: Pregnancy and cholelithiasis: Pathogenesis and natural course of gallstones diagnosed in early puerperium. Hepatology 17:1-4, 1993
51. van Erpecum KJ, van Berge Henegouwen GP, Verschoor L, et al.: Different hepatobiliary effects of oral and transdermal estradiol in postmenopausal women. Gastroenterology 100:482-488, 1991
52. Down RHL, Whiting MJ, Watts McKJ, et al.: Effect of synthetic oestrogens and progestagens in oral contraceptives on bile lipid composition. Gut 24:253-259, 1983
53. Bennion LJ, Ginsberg RL, Garnick MB, et al.: Effects of oral contraceptives on the gallbladder bile of normal women. N Eng J Med 294:189-192, 1976
54. Kern F Jr, Everson GT, DeMark B, et al.: Biliary lipids, bile acids and gallbladder function in human female: effects of contraceptive steroids. J Lab Clin Med 99:798-805, 1982
55. Kern F Jr, Everson GT: Contraceptive steroids increase cholesterol in bile: Mechanisms of action. J Lipid Res 28:828-837, 1987